Skip to main content
. 2021 Feb 12;4:225. doi: 10.1038/s42003-021-01743-9

Table 1.

Characteristics of selected 29 IgG linear epitopes for detection of SARS-CoV-2 infection.

S. no. Epitope ID. Epitope sequence Epitope length AA (start) AA (end) Protein name (Acc. MN908947) Severe COVID-19 Early (N = 22) Severe COVID-19 Late (N = 22) Mild- COVID-19 Early (N = 22) Mild-COVID-19 Late (N = 22) Asymptomatic COVID-19 (N = 12) SARS-CoV-1 (N = 11) Healthy controls (N = 10) Other HCoV (N = 11)
1 OP1 TAYNGYLTSSSKTP 13 1484 1497 ORF1ab polyprotein (pp1ab) 5/22 (23%) 4/22 (19%) 5/22 (23%) 5/22 (23%) 0/12 (0%) 1/11 (10%) 0/10 (0%) 1/11 (10%)
2 OP2 LVPNQPYPNASFDNF 14 1914 1928 8/22 (37%) 12/22 (55%) 3/22 (14%) 3/22 (14%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
3 OP3 NRFTTTLNDFNLVAMK 15 3484 3499 1/22 (5%) 1/22 (5%) 4/22 (19%) 3/22 (14%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
4 OP4 QGLLPPKNSIDAFKLNIK 17 3826 3843 5/22 (23%) 5/22 (23%) 4/22 (19%) 6/22 (28%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 2/11 (19%)
5 OP5 NTCVGSDNVTDFNAIATCDW 19 5419 5438 5/22 (23%) 13/22 (60%) 5/22 (23%) 6/22 (28%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
6 OP6 FYSYATHSDKFTDGV 14 6292 6306 7/22 (32%) 11/22 (50%) 0/22 (0%) 2/22 (10%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
7 SP1 TESNKKFLPFQQFGRDIAD 18 553 571 Surface glycoprotein 4/22 (19%) 15/22 (69%) 1/22 (5%) 9/22 (41%) 3/12 (25%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
8 SP2 TDAVRDPQTLEILDITPCS 18 573 591 6/22 (28%) 17/22 (78%) 1/22 (5%) 11/22 (50%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
9 SP3 QVAVLYQDVNCTEVPVAIHADQLTPTW 26 607 633 0/22 (0%) 9/22 (41%) 2/22 (10%) 4/22 (19%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
10 SP4 CASYQTQTNSPRRARSV 16 671 687 2/22 (10%) 4/22 (19%) 0/22 (0%) 1/22 (5%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
11 SP5 ARSVASQSIIAYTMSLGAENSVA 22 684 706 2/22 (10%) 6/22 (28%) 4/22 (19%) 4/22 (19%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
12 SP6 RALTGIAVEQDKNTQEVFAQV 20 765 785 11/22 (50%) 14/22 (64%) 2/22 (10%) 5/22 (23%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
13 SP7 FAQVKQIYKTPPIKDFGGFNF 20 782 802 5/22 (23%) 8/22 (37%) 1/22 (5%) 3/22 (14%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
14 SP8 NFSQILPDPSKPSKRS 15 801 816 1/22 (5%) 4/22 (19%) 0/22 (0%) 4/22 (19%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
15 SP9 KRSFIEDLLFNKVT 13 814 827 5/22 (23%) 8/22 (37%) 4/22 (19%) 5/22 (23%) 1/12 (9%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
16 SP10 PELDSFKEELDKYFKNHTSPDVD 22 1143 1165 15/22 (69%) 21/22 (96%) 9/22 (41%) 18/22 (82%) 8/12 (67%) 1/11 (10%) 0/10 (0%) 1/11 (10%)
17 SP11 SPDVDLGDISGINASVV 16 1161 1177 10/22 (46%) 20/22 (91%) 6/22 (28%) 13/22 (60%) 0/12 (0%) 1/11 (10%) 2/10 (20%) 1/11 (10%)
18 ORF3-1 EHDYQIGGYTEKWESGVKDCVVL 22 181 203 ORF3a protein 4/22 (19%) 7/22 (32%) 1/22 (5%) 2/22 (10%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
19 MP1 CDIKDLPKEITVATS 14 159 173 Membrane glycoprotein 0/22 (0%) 8/22 (37%) 0/22 (0%) 6/22 (28%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
20 MP2 QRVAGDSGFAAYSRY 14 185 199 0/22 (0%) 10/22 (46%) 0/22 (0%) 4/22 (19%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
21 ORF8-1 GSKSPIQYIDIGNYTVSCLPF 20 66 86 ORF8 protein 3/22 (14%) 12/22 (55%) 4/22 (19%) 3/22 (14%) 0/12 (0%) 0/11 (0%) 0/10 (0%) 1/11 (10%)
22 NP1 ALLLLDRLNQLESKMSG 16 220 236 Nucleocapsid phosphoprotein 3/22 (14%) 5/22 (23%) 2/22 (10%) 5/22 (23%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
23 NP2 NQLESKMSGKGQQQQGQTVTKKSA 23 228 251 12/22 (55%) 18/22 (82%) 8/22 (37%) 15/22 (69%) 7/12 (59%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
24 NP3 QTVTKKSAAEASKKPRQK 17 244 261 2/22 (10%) 7/22 (32%) 1/22 (5%) 4/22 (19%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
25 NP4 RGPEQTQGNFGDQELI 15 277 292 6/22 (28%) 3/22 (14%) 2/22 (10%) 3/22 (14%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
26 NP5 AYKTFPPTEPKKDKKKK 16 359 375 2/22 (10%) 5/22 (23%) 0/22 (0%) 2/22 (10%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
27 NP6 KDKKKKADETQALPQR 15 370 385 3/22 (14%) 7/22 (32%) 0/22 (0%) 5/22 (23%) 3/12 (25%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
28 NP7 ADETQALPQRQKKQQTVTLLPAADL 24 376 400 4/22 (19%) 17/22 (78%) 4/22 (19%) 9/22 (41%) 2/12 (17%) 0/11 (0%) 0/10 (0%) 0/11 (0%)
29 NP8 TLLPAADLDDFSKQLQQSMSSADS 23 393 416 14/22 (64%) 22/22 (100%) 6/22 (28%) 18/22 (82%) 7/12 (59%) 1/11 (10%) 0/10 (0%) 0/11 (0%)

Sequences (aa), length, aa location in protein is based on proteome of Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1 (accession no. MN908947).